Does UnitedHealth Group Inc (UNH) Stock Beat its Rivals in Health Care Plans?

Monday, May 18, 2020 12:07 PM | InvestorsObserver Analysts

UnitedHealth Group Inc (UNH) is near the top in its industry group according to InvestorsObserver. UNH gets an overall rating of 82. That means it scores higher than 82 percent of stocks. UnitedHealth Group Inc gets a 78 rank in the Health Care Plans industry. Health Care Plans is number 1 out of 148 industries.

Overall Score - 82
UNH has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on UNH!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With UnitedHealth Group Inc Stock Today?

UnitedHealth Group Inc (UNH) stock is trading at $296.41 as of 11:57 AM on Monday, May 18, an increase of $4.76, or 1.63% from the previous closing price of $291.65. The stock has traded between $294.11 and $299.72 so far today. Volume today is low. So far 1,446,040 shares have traded compared to average volume of 4,809,616 shares.

To see InvestorsObserver's Sentiment Score for UnitedHealth Group Inc click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

European ADRs Edge Lower in Monday Trading

Should You Buy Pacific Biosciences of California Inc (PACB) Stock on Monday?

Is Fennec Pharmaceuticals Inc (FENC) Stock About to Get Hot Monday?

Do Traders View Akers Biosciences Inc (AKER) Stock's Current Trend Positively?

Will T2 Biosystems Inc (TTOO) Beat the Rest of the Stocks in the Healthcare Sector?

Related Companies